Renaissance Technologies’s Biolase BIOL Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOL
Renaissance Technologies's BIOL Position: Q2 2023 in Review
Renaissance Technologies sold out of Biolase (BIOL) in Q2 2023, closing a stake of 1,388 shares — an estimated $39K sold.
Renaissance Technologies first reported a position in BIOL in Q3 2016 and held it in 15 quarters. The position peaked at $1.87M in Q1 2021. 25 funds tracked by Wall St. Rank hold BIOL as of Q2 2023.
- Renaissance Technologies reported no remaining Biolase position as of Q2 2023 after selling out during the quarter.
- Renaissance Technologies sold 1,388 Biolase shares in Q2 2023, an estimated $39K.
- Renaissance Technologies first reported a position in Biolase in Q3 2016 and held it in 15 quarters.
- Renaissance Technologies's Biolase position peaked at $1.87M in Q1 2021.
- 25 funds tracked by Wall St. Rank held Biolase as of Q2 2023.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.